Moreover some ribosomal proteins were highly induced (up to 119,98 fold change in expression for RPS11) as already observed in HUVECs treated with asymmetrical dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase considered a risk factor for cardiovascular disease [15]. This evidence concerns the gene RPS11 and cardiovascular disorder.